China is currently experiencing a surge in the number of people affected by HMPV. There are multiple people visiting hospitals on a daily basis over the last few days with respiratory symptoms. Lets Know a few things about this virus. Human metapneumovirus (HMPV) is a respiratory virus that belongs to the Paramyxoviridae family. First identified in 2001, it primarily affects the respiratory tract, leading to infections that range from mild upper respiratory symptoms to severe lower respiratory diseases. It is most common in children, the elderly, and those with compromised immune systems, but it can infect healthy individuals as well.
HMPV is a globally distributed respiratory virus that circulates primarily during the winter and spring months. It affects all age groups, but infants, young children, the elderly, and immunocompromised individuals are most at risk for severe disease, including bronchiolitis and pneumonia. Although it is often underreported due to mild cases in healthy adults, it is a significant cause of respiratory infections, especially in young children.
HMPV spreads primarily through respiratory droplets when an infected person coughs, sneezes, or talks. It can also spread by direct contact with contaminated surfaces, such as doorknobs, handrails, or shared objects, followed by touching the face, especially the eyes, nose, or mouth. Close contact with infected individuals, including in households or healthcare settings, increases the risk of transmission. It is highly contagious, and outbreaks often occur during the winter and spring months. Since the virus can be transmitted before symptoms appear, asymptomatic individuals can also contribute to its spread.
HMPV causes a range of symptoms, from mild to severe, depending on the individual’s age and health status:
The most common method is polymerase chain reaction (PCR), which detects the viral RNA in respiratory samples such as nasal swabs or throat specimens. It is highly sensitive and can accurately identify the virus, distinguishing it from other respiratory viruses. Viral culture or immunofluorescence assays can also be used, though they are less commonly employed.
There is no specific antiviral treatment for HMPV infection. Treatment mainly focuses on supportive care. This includes hydration, rest, and over-the-counter medications like acetaminophen or ibuprofen to manage fever and pain. In more severe cases, especially in vulnerable populations, supplemental oxygen may be needed, and nebulized medications such as bronchodilators may help with breathing. Hospitalization is necessary for severe respiratory distress or complications, where mechanical ventilation may be required. Although no antiviral drugs are approved for HMPV, ongoing research aims to identify effective treatments. Symptom management and respiratory support are key to recovery.
Preventing HMPV infection primarily focuses on reducing transmission.
HMPV generally doesn't pose a significant threat to healthy individuals, as most recover with mild symptoms like a cold. However, it can cause severe respiratory illness in vulnerable populations, including infants, the elderly, and those with compromised immune systems. In these groups, HMPV can lead to bronchiolitis, pneumonia, and other serious conditions, sometimes requiring hospitalization. While there is no specific treatment or vaccine, supportive care is usually effective. Though not an immediate concern for everyone, outbreaks can place a strain on healthcare systems, making it important to monitor and practice preventive measures.
Disclaimer: This article is written by Practo for informational and educational purposes only. The content presented on this page should not be considered as a substitute for medical expertise. Please "DO NOT SELF-MEDICATE" and seek professional help regarding any health conditions or concerns. Practo will not be responsible for any act or omission arising from the interpretation of the content present on this page.
Book an appointment with the top
Doctor near you.